Divi's Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

53.09

53.09

53.09

53.09

53.09

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

12,652.33

11,638.26

9,218.48

7,263.60

6,920.22

Loan funds

Secured loans

-

-

0.35

33.63

105.60

Unsecured loans

-

-

-

-

-

Total

12,705.42

11,691.35

9,271.92

7,350.32

7,078.91

Uses of funds

Fixed assets

Gross block

6,335.93

5,599.99

4,670.94

3,496.51

2,624.60

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,617.17

1,279.02

971.93

720.25

537.16

Net block

4,718.76

4,320.97

3,699.01

2,776.26

2,087.44

Capital work-in-progress

211.88

469.93

710.62

919.69

491.91

Investments

84.41

79.37

7.37

978.72

1,952.96

Net current assets

Current assets, loans & advances

9,336.57

8,437.59

6,306.77

3,839.44

3,507.87

Less : current liabilities & provisions

1,646.20

1,616.51

1,451.85

1,163.79

961.27

Total net current assets

7,690.37

6,821.08

4,854.92

2,675.65

2,546.60

Miscellaneous expenses not written

-

-

-

-

-

Total

12,705.42

11,691.35

9,271.92

7,350.32

7,078.91

Notes:

Book value of unquoted investments

84.41

79.37

7.37

7.37

7.37

Market value of quoted investments

-

-

-

971.35

1,945.59

Contingent liabilities

736.98

1,259.90

1,107.13

1,223.83

1,031.35

Number of equity sharesoutstanding (Lacs)

2654.69

2654.69

2654.69

2654.69

2654.69